BioNTech SE BNTX
NASDAQ BNTX
$104.18 +1.30 (+1.26%)
As of: Sep 4, 2026 · 2:29 PM EDT

BioNTech SE (BNTX) Shares Outstanding (Entity) (2018 - 2025)

Analysis

BioNTech SE (BNTX) Shares Outstanding (Entity) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 214.24 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 575.00 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 218.28 Mn
10 BioNTech SE 25.18 Bn 11.52 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 252.88 Mn
Dec 31, 2024 239.97 Mn
Dec 31, 2023 237.73 Mn
Dec 31, 2022 240.99 Mn
Dec 31, 2021 246.81 Mn
Dec 31, 2020 235.44 Mn
Dec 31, 2019 211.50 Mn
Dec 31, 2018 190.71 Mn